Authors
Dan Liu, Nazgol Esmalian Afyouni, Qingliang Yang, Svetllana Kallogjerovic, Bojana Gligorijevic, Satya Kunapuli, Laurie E Kilpatrick, Mohammad F Kiani
Published in
Lab on a chip. Jul 31, 2026. Epub Jul 31, 2026.
Abstract
Current preclinical models fail to capture human neutrophil-endothelial interactions central to sepsis, contributing to repeated failure of candidate therapeutics in clinical trials. Here, we present a biomimetic microphysiological system (bMPS) integrating primary human endothelial cells, human neutrophils and controlled chemoattractant gradients under physiological flow in a microvascular network. This platform enables real-time visualization of neutrophil adhesion and transmigration, along with quantitative analysis of endothelial barrier integrity. We demonstrate chemoattractant-dependent differential neutrophil recruitment to host-derived IL-8 and bacterial-derived fMLP and differential responses to two different therapeutics: the PAF receptor antagonist BN-52021 reduces recruitment in response to IL-8 but not to fMLP, whereas the PKC-δ inhibitor suppresses adhesion, transmigration, and NET formation to both IL-8 and fMLP. Confocal imaging and quantitative analysis demonstrate that Cytomix-induced endothelial barrier disruption in primary human lung microvascular endothelial cells (HLMVECs) is significantly ameliorated by BN-52021 and the PKC-δ inhibitor-restoring VE-cadherin integrity and reducing intercellular gaps. This bMPS provides a predictive, human-relevant platform for function-focused sepsis drug screening.
PMID:
42533817
Bibliographic data and abstract were imported from PubMed on 31 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 14
- Comments 0